DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Ticker SymbolDRIO
Company nameDarioHealth Corp
IPO dateMar 08, 2013
CEOMr. Erez Raphael
Number of employees196
Security typeOrdinary Share
Fiscal year-endMar 08
Address322 W 57Th St. #33B
CityNEW YORK
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code10019
Phone16466654667
Websitehttps://shop.mydario.com/
Ticker SymbolDRIO
IPO dateMar 08, 2013
CEOMr. Erez Raphael
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data